British American Tobacco p.l.c. ADR (BTI)
British American Tobacco: The Market Underestimates How Big Velo Can Become
British American Tobacco earns a Buy rating at ~$53, driven by Velo's rapid growth and improving profit mix. Velo's dominance in Modern Oral, with strong US and European market shares, underpins BTI's long-term growth prospects. New Categories' margin expansion and cost savings initiatives position BTI for 5–8% EPS growth and attractive total returns.
BTI: This Retracement Hands Income Investors A Fresh Opening Yielding 6.31%
British American Tobacco trades at 11x 2026 earnings with a 6.31% yield, despite strong operational progress and robust free cash flow guidance. BTI's New Category revenue grew 18% with contribution margin rising to 13.8%, and Velo now leads the global Modern Oral market. Management reaffirmed 2030 targets: 3–5% revenue growth, 4–6% APFO growth, 5–8% EPS growth, and over £50 billion FCF from 2024–2030.
British American Tobacco: Rich Dividends And Diversified Nicotine Assets - Competition/Legal Risks Ahead
A diversified combustible portfolio across premium, value, and discount positioning along with high-growth vapor/oral offerings underscores BTI's future resilience amid secular declines. H2'26 may deliver expanded US total nicotine volume shares, given the upcoming launches of Velo with higher strengths/limited edition flavors and Vuse Pro's fruit-flavored pods. The recent stock price meltdown triggers BTI's discounted P/E of 11.13x, richer forward dividend yields of 6.28%, and expanded upside potential to my LTPT of $64.
British American Tobacco p.l.c. (BTI) Analyst/Investor Day Transcript
British American Tobacco p.l.c. (BTI) Analyst/Investor Day Transcript
BTI vs. PM: Which Tobacco Dividend Will Actually Survive the Industry's Decline?
Both BTI and PM fund generous dividends from a shrinking cigarette business, but one company's smoke-free pivot has already changed what its payout is built on, and that gap matters far more than the headline yield difference.
British American Tobacco Targets Smokeless Growth, £50B Cash Flow by 2030
British American Tobacco NYSE: BTI outlined its Horizon 2030 strategy at its 2026 Capital Markets Day, targeting growth in smokeless nicotine products while maintaining combustibles as a cash-generating business that funds investment, dividends and share buybacks.
British American Tobacco Targets Horizon 2030 Growth With Velo, U.S. Turnaround and AI
British American Tobacco NYSE: BTI used its 2026 Capital Markets Day to outline its Horizon 2030 strategy, emphasizing growth in modern oral nicotine products, a turnaround in the U.S. business, continued cash generation from combustibles and greater use of artificial intelligence across operations.
British American Tobacco Targets 3%-5% Growth as Smokeless Push Powers Horizon 2030
British American Tobacco NYSE: BTI used its Horizon 2030 Capital Markets Day in Winston-Salem, North Carolina, to outline plans to expand its smokeless portfolio, advocate for tobacco harm reduction regulation and deliver growth, margin expansion and shareholder returns through 2030.
4 Tobacco Stocks Turning Huge Cash Flow Into High-Yield Dividends
Tobacco companies spend almost nothing on new equipment yet generate billions in cash, and a handful of US-listed names funnel that surplus straight into shareholder pockets through yields that most sectors cannot touch.
3 Tobacco Stocks to Watch Amid Changing Industry Dynamics
PM, BTI and MO are navigating volume pressure and rising costs by expanding smoke-free portfolios and adapting to shifting consumer demand.
British American Tobacco: A Long-Term Perspective On This 6% Yielder
British American Tobacco's Modern Oral segment grew 65.9% in H1'26 and is now the company's largest New Category while holding a 39.2% volume share in top markets. Sweden, Norway, Poland, and the US show how oral nicotine expands the pool of users as cigarettes decline. A reverse DCF shows that the shares at $55 look to price Modern Oral at a mere 16% CAGR, while this segment has been compounding at 47-66% recently.
British American Tobacco: The Pullback Is A Gift For Income Investors
British American Tobacco offers compelling value trading at 11.5x forward earnings with a 6% dividend yield. NGP revenue grew 18% YoY, with Velo now the global leader in Modern Oral and strong U.S. market share gains. Management guides for 5–8% adjusted EPS growth in 2026, supported by NGP momentum and improving profitability.
